The U.S. Food & Drug Administration (FDA) has issued a recall for I.V. flush syringes made by Nurse Assist Inc., after patients developed severe B. cepacia infections while using intravenous prepackaged saline flushes.

Free Confidential Lawsuit Evaluation: If you or a loved one developed an infection after using an I.V. flush syringe, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Update: Liquid Stool Softeners Recalled for B. Cepacia Contamination

August 9, 2017 – Rugby Laboratories is recalling its Diocto liquid and Diocto syrup laxatives over potential contamination with B. cepacia, according to an FDA Recall Notice issued Tuesday. The agency notified Rugby of the problem after receiving several reports of infection in patients who had used the laxatives.

What’s the Problem?

October 5, 2015 – This recall affects all unexpired Nurse Assist I.V. Flush Syringes from the following lot codes:

Product Code         Product Description
1203                           IV Flush Syringe, 3 ml fill
1205                           IV Flush Syringe, 5 ml fill
1210                           IV Flush Syringe, 10 ml fill
1210-BP                    IV Flush Syringe, 10 ml fill

These products were distributed between February 16 and September 30, 2016. Lot code information is located on the outer panel case, back panel of the inner carton and on each syringe label. To date, no B. cepacia infections or other injuries have been linked to the flush syringes.

What Happens when B. Cepacia Enters the Body?

Once B. cepacia enters the body, there are 3 possible things that can happen:

  • The bacteria colonizes the lungs, causes no symptoms and has no long-term effect;
  • The bacteria colonizes the lungs and causes damaging lung infections and inflammation that lead to a slow deterioration of lung function, or
  • In the worst case scenario, B. cepacia can spread throughout the body causing cepacia syndrome, a potentially deadly condition that causes rapid deterioration of lung function.

Symptoms

The symptoms of B. cepacia, if there are any, are the same as the symptoms of any lung infection and are common in people with cystic fibrosis even if they don’t have B. cepacia. These symptoms include:

  • Fever
  • Cough
  • Congestion
  • Shortness of breath
  • Wheezing

B. Cepacia Infections Linked to Nurse Assist Flush Syringes Reported in New Jersey

November 14, 2016 – At least 13 people in New Jersey have recently developed B. cepacia infections associated with an outbreak linked to contaminated IV flush syringes made by Nurse Assist. The New Jersey Department of Health last month issued alerts to long-term healthcare facilities about potential B. cepacia contamination in flush syringes from the Texas-based supplier. The agency urged providers to discontinue use of the products immediately.

Can I Participate in a Class Action?

The problem with Nurse Assist I.V. Flush Syringes is a recent development, and no class action lawsuit has yet been filed over B. cepacia infections or other injury alleged from the product. However, our lawyers are accepting potential individual lawsuits on behalf of injured parties. If we determine that you have a valid claim, you may be entitled to compensation to assist with medical expenses, lost wages, pain and suffering, and other damages.

Do I Have a Nurse Assist I.V. Flush Syringe Lawsuit?

The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in flush syringe lawsuits. We are handling individual litigation nationwide and currently accepting new B. cepacia infection cases in all 50 states.

Free Case Evaluation: Again, if you or a loved one was injured, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

FREE Confidential Case Evaluation

To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.

*
*
*